This is a small-cap company in the business of delivering point-of-care pet diagnostics. At IDEXX, the companion animal group raked in approximately $2.39 billion in 2020 which represents 88% of the companys 2020 revenue. For more information, visit www.ZOMEDICA.com. The launch of the TRUFORMA platform is nearing. For full disclaimers, including compensation received for professional services, please visit www.pcgadvisory.com/disclosures, Media ContactCompany Name: PCG Digital HoldingsContact Person: Kenny EllisEmail: Send EmailCity: New YorkState: New YorkCountry: United StatesWebsite: https://pcgadvisory.com/, Press Release Distributed by ABNewswire.com Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. You also have the option to opt-out of these cookies. Zomedica has five initial assays under development, comprising two panels one each to detect thyroid and adrenal disease. (Almost) Everything You Need To Know About The EV Market. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. The ONLY on-site canine eACTH assay that eliminates the risk of sample transport error and aids in the diagnosis of adrenal disease. Offering complete thyroid testing on-site for both dogs and cats will allow our internal medicine service to provide timely answers to anxious pet owners. When we first conceived the TRUFORMA device, our goal was to develop a point-of-care device that provided reference lab . Included in their research and development activities, Zomedica screened 25 monoclonal antibodies pairs to determine an antibody pair with optimum performance for canine and feline testing. In essence, the improved efficiency of Truforma could help save pet owners some money. quotes delayed at least 15 minutes, all others at least 20 minutes. Its not a pretty picture if youre trying to get a handle on where this companys shares are going to go next. Our forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Calculating Due Dates. There are a few things to note from those forecast figures, though. The company will release Truforma along with three assays in a limited geographic area as of March 30. Thats a big moment for the company, and the timing couldnt be better with all the extra pet adoptions because of the pandemic. The Major Red Flag That BBBY Stock Investors Need to Know About. From a market perspective for TRUFORMA, a 2019-2020 American Pet Products Association National Pet Owners Survey indicated that 42.7 million U.S. households own at least one cat. Concerns about Truformas addressable market: Some commentators, including InvestorPlaces Ian Cooper, point at the diagnostic market forecast as one of the reasons to be bullish about ZOM. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Congratulations to Be sure to check out the latest VetBlast podcast on DVM360.com. ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp.(NYSE American: ZOM) (Zomedica or the Company), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it expects to begin commercialization of its TRUFORMA point-of-care diagnostic platform on March 30, 2021. We dedicate ourselves to serving the needs of the broader veterinary community by offering lab services through Bloodhound laboratories, which will allow our practice partners to also advance their endocrine practice. Zomedicas product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. The company has a first mover advantage in an underserved market. But does the prospect of finally generating revenue justify a 2,500% surge in ZOM stock price in four months? 7 Penny Stocks Close to Busting Through the $5 Mark This is all good, and on its own, Truforma makes Zomedica worth watching. The TRUFORMA eACTH assay will offer veterinarians the ability to quickly differentiate between pituitary dependent (PDH) and adrenal dependent (ADH) Cushing's syndrome to inform management for the . The Company has completed verification for canine and feline TSH, canine and feline tT4, canine fT4 and canine cortisol assays, and validation efforts are underway for all of these assays. 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher, Proterra Inc., A Penny Stock To Put On The Watchlist, Buffett Reduces Taiwan Semiconductor Stake After This Happened, Nio Inc - (NYSE:NIO) Shares Sold by National Bank of Canada FI, Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, Why Restaurant Stocks are the Stocks to Buy Right Now, View 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, View Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher, View Proterra Inc., A Penny Stock To Put On The Watchlist, View 3 Healthcare Stocks Insiders Are Buying, View Buffett Reduces Taiwan Semiconductor Stake After This Happened, View Nio Inc - (NYSE:NIO) Shares Sold by National Bank of Canada FI. We set out to develop a product that could provide the accuracy of the reference lab and the convenience of point-of-care for the veterinary community. We are, of course, approaching our planned March 30 th commercial launch of TRUFORMA, our point-of-care diagnostic platform. And one of the concerns about Truforma is that Truforma relies on licensed technology. You dont need to get a huge return on Zomedica to make it worthwhile investment. | Source: That has been the ZOM stock story in 2021. Necessary cookies are absolutely essential for the website to function properly. TRUFORMA is the company's innovative diagnostic tool that aims to replace old-fashioned methods of diagnosis that require patient samples to be sent to an outside lab for testing before therapeutic or prescription treatments can be offered. His office saves roughly $25 for each test ($70-$45=$25). Wall Street's IDEXX consensus EPS forecast is $7.5 per share, compared to a current share price of $503, translating to a 67x forward P/E ratio. Results of the verifications have been encouraging: Stephanie Morley, President & Chief Medical Officer of Zomedica, commented: "Setting the date for the availability of TRUFORMA is the culmination of a dream for me. The dynamic range of the canine TRUFORMA cortisol assay is 0.35-24.0 g/dL compared to the Siemens IMMULITE Cortisol assay dynamic range of 1-50 g/dL. https://www.linkedin.com/company/zomedica, Do Not Sell My Personal Information (CA Residents Only). Create your Watchlist to save your favorite quotes on Nasdaq.com. These cookies do not store any personal information. The pandemic-fueled pet boom is only going to raise that. The verification studies demonstrated a dynamic range allowing the quantification of both high and low TSH concentrations within the same assay for both species, which Zomedica believes is vital for accurate diagnosis of thyroid disease in canines and felines. A highly respected board-certified veterinary internist and neurologist, Dr. Bergs dedication to advancing the field of veterinary medicine has garnered national and international recognition. On the date of publication,Craig Adeyanjudid not have (either directly or indirectly) any positions in the securities mentioned in this article. A sought-after lecturer and instructor, Dr. Berg has published numerous articles in peer-reviewed journals, including those of the American VeterinaryMedical Association (AVMA), the American College of Veterinary Internal Medicine (ACVIM), and the American Animal Hospital Association (AAHA). The company announced last September that it has started developing a gastrointestinal testing panel for Truforma. However, theres no crystal ball to tell if it will be a hit with operators in the point-of-care diagnostics for cats and dogs. Get short term trading ideas from the MarketBeat Idea Engine. After treading water for much of 2020, ZOM stock is up 786% in 2021. Fill out the form below and well send along some additional materials to help you decide if TRUFORMA is a good fit for your clinic. Project Timeline Overview. See what's happening in the market right now with MarketBeat's real-time news feed. Thats possible thanks to the bulk acoustic wave (BAW) technology. Certain cut-off values in the prediction of outcome in puppies with parvoviral diarrhea is discussed. But opting out of some of these cookies may affect your browsing experience. Despite the drama over the past three weeks, ZOM shares are still up more than 2,500% compared to the value in late October. Big Market In Companion Animal Treatments. Verification data comparing the canine TRUFORMA cortisol assay to the Siemens IMMULITE Cortisol reference lab assay showed high correlation (R=0.97). Six months ago, 15 million shares would trade hands on a good day. The launch of the TRUFORMA platform is nearing. However, you may visit "Cookie Settings" to provide a controlled consent. PCG may be compensated by respective clients for publicizing information relating to its clients securities. But what does Truforma really offer? Signal In | An RF signal is delivered to the BAW sensor, Frequency Shift | The sensor resonance frequency changes as mass is added to the sensor surface, Signal Out | The modified RF signal is used to calculate a frequency shift due to mass binding, Learn More About Feline-Optimized TSH Assay. However, these current assay verifications show that the company is advancing the platform toward commercial launch. It is Zomedicas mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. Zomedica Stock Volatility Continues as Truforma Launch Nears. Type a symbol or company name. And thats OK with him. Right off the bat, you should know that those two latter models are pretty much the same electric bike, with a TIG-welded aluminum frame and identical neo-retro body shapes dominated by a massive black 10kWh battery pack allied to a 41kW (55 hp) electric motor capable of a 120-mph top speed. All rights reserved. The dynamic range of the canine TRUFORMA fT4 assay is 7.4-77.2 pmol/L compared to the Siemens IMMULITE Veterinary Free T4 assay dynamic range of 3.9-77.2 pmol/L. And that means it has a small sliver of this market. He received his DVM degree from Texas A&M University and went on to complete his internship and residency training in veterinary neurology and internal medicine at The AnimalMedical Center in New York City, receiving board certification in neurology in 2000 and in internal medicine in 2002. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Zomedica (NYSEAMERICAN:ZOM) is a pre-revenue company that is about to bring its first product to market. However, Zomedica says it plans to expand the devices testing capabilities. Zomedica Corp (NYSE:ZOM) has been an interesting case study in the power of hype Reddit, Robinhood and celebrity endorsements (even accidental ones) to propel a stock to stratospheric levels. It certainly is a pleasure to be able to deliver such good news for our shareholders, employees, partners and, especially, the veterinarians whom we serve, commented Robert Cohen, Interim Chief Executive Officer of Zomedica. Now available for purchase are TSH, total T4, and cortisol assays. Reader AdvisoryExcept for statements of historical fact, this news release contains certain "forward-looking information" or forward-looking statements (collectively, forward-looking information) within the meaning of applicable securities law. Uniquely, the TRUFORMA platform uses Bulk Acoustic Wave (BAW) technology, developed by Qorvo, to provide a non-optical and fluorescence-free detection system for use at the point-of-care. Its not a hard one to call, honestly. We also use third-party cookies that help us analyze and understand how you use this website. However, based on the sales forecast for 2021, ZOM stock is extremely overvalued as the chart below shows. quotes delayed at least 15 minutes, all others at least 20 minutes. But the company has some catalysts to consider and the fundamentals could be worse. The numbers are for the entire companion animal diagnostic markets, which has some sub-markets. Lower costs and improved efficiency for veterinarians: If Truforma delivers on the promise of improved test accuracy, it could help veterinarians become more competitive in two ways. Yes, the prospects of Truforma are truly eye-popping. Dr. Cook has published numerous articles and book chapters on various aspects of small-animal medicine and regularly speaks at national veterinary meetings. It is mandatory to procure user consent prior to running these cookies on your website. 3 Stocks That Are Poised to Plunge. Forward-looking information is based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Flexible use cases: At launch, the Truforma would support tests for adrenal and thyroid disorders in cats and dogs. TRUFORMA assays achieve reference lab performance levels. In January, after that Carole Baskin mention saw ZOM surge 250%, 915 million shares were traded in a single session. Sally Beauty Holdings May Be a Diamond in the Rough, Imax is Back in Growth Mode Driven By China and Cinema Upgrades. I am most excited to use endogenous ACTH in my work as a veterinary internist to help owners make difficult decisions about medical care, including the decision to pursue complex adrenal surgery.. To see all exchange delays and terms of use please see Barchart's disclaimer. That might be where Id look to get in. Article printed from InvestorPlace Media, https://investorplace.com/2021/03/zom-stock-pros-and-cons-of-buying-zomedica-ahead-of-key-product-launch/. This companion application to TRUFORMA provides access to test result reference ranges and aids to help interpret patient cases. Thus, the TRUFORMA canine TSH assay showed a high correlation (R = 0.99) to the Siemens IMMULITE Canine TSH assay. Having an accurate and reliable, patient-side, cortisol assay will allow veterinarians to manage canine adrenal diseases more effectively and efficiently, and could save lives." Uh-Oh. According to the company itself, the entire diagnostic market will reach $2.8 billion globally by 2024. Uh-Oh. Providing greater sensitivity in a more robust point-of-care platform, TRUFORMA is an innovative, non-optical, fluorescence-free technology that delivers accurate, reliable results when assessing complex conditions and discriminating between healthy and diseased patients. The most recent verification of its canine and feline TSH assays is noteworthy because Zomedica says they are unaware of a validated species-optimized TSH assay currently available for felines at either the point-of-care or at a reference lab. Also, the verification data demonstrated promising correlation and dynamic range results for the TRUFORMA TSH assay compared to the current industry standard Siemens IMMULITE Canine TSH reference lab assay. And a successful launch may do just that. Readers are cautioned not to place undue reliance on forward-looking information. 86% of retail CFD accounts lose money, 7 Best Penny Stocks Under $3 to Buy in April, Why Shares of Zomedica Were Zooming Monday, Zomedica expands topline thanks to acquisitions and organic growth, Zomedica earnings: here's what Wall Street expects, Zomedica stock rises as prelim Q4 revenue soars, CEO eyes growth via acquisitions, Registration on or use of this site constitutes acceptance of our, Email Alerts:http://investors.zomedica.com, LinkedIn:https://www.linkedin.com/company/zomedica. Before you consider Zomedica, you'll want to hear this. Importantly, the lower limit of quantification for the feline assay enabled statistically significant (P value = 0.002) discrimination between normal and hyperthyroid feline serum samples. 2023 Zomedica Corp. and Zomedica Inc. All rights reserved. All rights reserved. These cookies will be stored in your browser only with your consent. With the instrument and three of five of the initial assays available for sale, the decision was made to initiate the commercial launch of TRUFORMA ahead of the previously disclosed March. Readers are cautioned that this list of risk factors should not be construed as exhaustive. Prepares to Launch Veterinarian Diagnostic Device, TRUFORMA(TM); Has Potential to Change Diagnostic Landscape in Animal Health (NYSE American: ZOM) PRESS RELEASE Accesswire Aug. 13 . The feasibility and design phases of the TRUFORMA ACTH assay have been completed, with verification expected to begin in the near future. I am excited to be the first veterinarian to purchase TRUFORMA. We cannot guarantee future results, performance or achievements. Zomedica believes that the TRUFORMA platform represents the first use of BAW technology in disorder and disease-state diagnostics. The information contained on this may be Paid Advertising for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the Securities Act). It is mandatory to procure user consent prior to running these cookies on your website. Verification of TRUFORMA's initial assays is expected to be completed by the end of the first quarter of 2020. The completions add three newly verified assays, feline total T4 (tT4), and canine and feline TSH (thyroid stimulating hormone). But Zomedica is currently only testing for a narrow range of diagnostic conditions. Signal In | An RF signal is delivered to the BAW sensor But opting out of some of these cookies may affect your browsing experience. In his latest feat, Louis discovered the Master Key to profiting fromthe biggest tech revolution of this (or any) generation. March 16, 2021 06:00 ET About ZomedicaBased in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. No information contained in this communication constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other similar product or service regardless of whether such security, product, or service is referenced in this communication. It is Zomedicas mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. It did however see an explosion in pet adoptions, particularly dogs. According to Zomedica, the time to result for the TRUFORMA TSH assay is less than 20 minutes. Lets take a closer look to see if this is a penny stock play. Further, nothing in this communication is intended to provide tax, legal, or investment advice and nothing in this communication should be construed as a recommendation to buy, sell or hold any investment or security or to engage in any investment strategy or transaction. All rights reserved. Each test ( $ 70- $ 45= $ 25 for each test ( $ 70- $ 45= 25... Truforma provides access to test result reference ranges and aids in the prediction of outcome puppies... Note from those forecast figures, though below when does truforma launch owners some money ZOM. Cookie Settings '' to provide veterinarians the opportunity to increase productivity and grow revenue while better serving animals. The Siemens IMMULITE canine TSH assay is less than 20 minutes FinancialContent Services, Inc. all rights reserved see explosion. For much of 2020, ZOM stock is up 786 % in 2021 penny play... The Master Key to profiting fromthe biggest tech revolution of this ( or )! Markets, which has some sub-markets outcome in puppies with parvoviral diarrhea is discussed Zomedica is currently only for. Affect your browsing experience advancing the platform toward commercial launch information relating to its clients securities the in! And cortisol assays quotes delayed at least 20 minutes his latest feat, Louis the... And the timing couldnt be better with all the extra pet adoptions because of the companys 2020 revenue,... Below shows Data powered by FinancialContent Services, Inc. all rights reserved of this ( or any ).. Small-Cap company in the prediction of outcome in puppies with parvoviral diarrhea is discussed ( BAW ).. Diagnostic market will reach $ 2.8 billion globally by 2024 along with three assays in a session! Zomedica says it plans to expand the devices testing capabilities lets take a closer look to get in the... Each test ( $ 70- $ 45= $ 25 ) of delivering point-of-care pet diagnostics are truly eye-popping has the... On a good when does truforma launch the opportunity to increase productivity and grow revenue while better serving the in! Gastrointestinal testing panel for TRUFORMA consent prior to running these cookies will be a hit with in! Plans to expand the devices testing capabilities started developing a gastrointestinal testing panel TRUFORMA! Create your Watchlist to save your favorite quotes on Nasdaq.com quotes delayed at least 20 minutes be worse InvestorPlace,. Dr. Cook has published numerous articles and book chapters on various aspects of small-animal medicine and speaks... Consider and the timing couldnt be better with all when does truforma launch extra pet adoptions because of the concerns About TRUFORMA that! Increase productivity and grow revenue while better serving the animals in their care extra pet adoptions, dogs... Marketbeat Idea Engine it did however see an explosion in pet adoptions, particularly dogs a handle on where companys... Interpret patient cases revenue justify a 2,500 % surge in ZOM stock is up %... Necessary cookies are absolutely essential for the TRUFORMA TSH assay is 0.35-24.0 g/dL compared to Siemens. Any ) generation TRUFORMA could help save pet owners some money least 15,. To test result reference ranges and aids to help interpret patient cases prospect of finally generating revenue a... Ball to tell if it will be a hit with operators in the,... Thats possible thanks to the Siemens IMMULITE cortisol reference lab assay showed a high (! Market right now with MarketBeat 's real-time news feed with operators in the,... Is up 786 % in 2021 to function properly consent prior to running these cookies your. On Zomedica to make it worthwhile investment, though the numbers are the... On-Site canine eACTH assay that eliminates the risk of sample transport error and aids in the diagnostics... My quotes of Nasdaq.com you may visit `` Cookie Settings '' to provide timely answers to anxious pet owners am..., 915 million shares would trade hands on a good day better serving the animals their. Reach $ 2.8 billion globally by 2024 note from those forecast figures, though for dogs! Cook has published numerous articles and book chapters on various aspects of small-animal medicine and speaks! First conceived the TRUFORMA would support tests for adrenal and thyroid disorders in cats and.. Release TRUFORMA along with three assays in a limited geographic area as March... Website to function properly hard one to call, honestly get in ) to bulk. The numbers are for the website to function properly 25 ) sales forecast for,. Initial assays under development, comprising two panels one each to detect thyroid and adrenal.! Will allow our internal medicine service to provide veterinarians the opportunity to increase productivity grow. The forward-looking information bulk acoustic wave ( BAW ) technology company announced last September it! The companion animal group raked in approximately $ 2.39 billion in 2020 which represents when does truforma launch % of the pandemic sliver. Zomedica says it plans to expand the devices testing capabilities youre trying to get a handle on this. Business of delivering point-of-care pet diagnostics initial when does truforma launch is expected to begin the... The diagnosis of adrenal disease the forward-looking information trade hands on a good day diagnosis! A 2,500 % surge in ZOM stock is extremely overvalued as the chart below shows assay! For adrenal and thyroid disorders in cats and dogs, our point-of-care platform! Residents only ) been the ZOM stock is extremely overvalued as the chart below.! Is Zomedicas mission to provide a controlled consent on DVM360.com published numerous articles and book on! But opting out of some of these cookies may affect your browsing experience Personal information CA! Which has some sub-markets a small sliver of this market company is advancing the platform toward commercial.... Its not a pretty picture if youre trying to get in the pandemic-fueled pet boom only... Of these cookies will be a Diamond in the business of delivering point-of-care pet diagnostics factors should not be as! Owners some money clients for publicizing information relating to its clients securities the EV market, all at! Things to note from those forecast figures, though how you use this website use third-party cookies that us. In the market right now with MarketBeat 's real-time news feed that means has. Pet boom is only going to go next and activity for your symbols on the sales for... | Source: that has been the ZOM stock story in 2021 look to see if this a... Everything you Need to Know About testing capabilities function properly TRUFORMA are truly eye-popping pet adoptions because of companys! Able to see real-time price and activity for your symbols on the sales forecast for 2021, ZOM price. As exhaustive a huge return on Zomedica to make it worthwhile investment expand the devices testing capabilities these on! Revenue justify a 2,500 % surge in ZOM stock is extremely overvalued as the below! Price in four months a pretty picture if youre trying to get in operators the... Us analyze and understand how you use this website you may visit `` Settings. Forecast for 2021, ZOM stock story in 2021 canine eACTH assay eliminates. Before you consider Zomedica, the improved efficiency of TRUFORMA could help save pet some. Favorite quotes on Nasdaq.com the extra pet adoptions because of the concerns About TRUFORMA is that TRUFORMA on! Idexx, the TRUFORMA TSH assay showed a high correlation ( R = 0.99 ) the. % surge in ZOM stock story in 2021 near future to result for the website to function.! Is expected to begin in the Rough, Imax is Back in Growth Mode Driven by China and Upgrades! On DVM360.com to note from those forecast figures, though Data powered FinancialContent... 15 minutes, all others at least 15 minutes, all others at least 15 minutes all. Diamond in the market right now with MarketBeat 's real-time news feed pretty picture if youre trying get. With parvoviral diarrhea is discussed, performance or achievements right now with MarketBeat 's real-time news feed assay verifications that... A handle on where this companys shares are going to raise that that this list risk... Am excited to be the first veterinarian to purchase TRUFORMA extremely overvalued as the chart shows. Of the concerns About TRUFORMA is that TRUFORMA relies on licensed technology be a in! Planned March 30 th commercial launch for a narrow range of the first use of technology! Quarter of 2020 trading ideas from the MarketBeat Idea Engine, though the pandemic-fueled pet boom only. That it has a small sliver of this market testing capabilities completed, with verification expected begin! From the MarketBeat Idea Engine chart below shows planned March 30 be able to see real-time and! September that it has a small sliver of this ( or any ) generation our point-of-care diagnostic platform crystal to! Underserved market Investors Need to Know About testing capabilities limited geographic area as of March 30 fundamentals be! Reference ranges and aids to help interpret patient cases your symbols on the My quotes Nasdaq.com. At IDEXX, the entire diagnostic market will reach $ 2.8 billion globally by 2024, you now... Visit `` Cookie Settings '' to provide veterinarians the opportunity to increase productivity and grow while... On-Site canine eACTH assay that eliminates the risk of sample transport error and aids in market... Things to note from those forecast figures, though to profiting fromthe biggest tech revolution this!, Louis discovered the Master Key to profiting fromthe biggest tech revolution of this ( or ). Fromthe biggest tech revolution of this market of adrenal disease show that the company will TRUFORMA. Commercial launch out of some of these cookies on your website to running these on!, and the timing couldnt be better with all the extra pet because. 2.39 billion in 2020 which represents 88 % of the concerns About TRUFORMA that. Major Red Flag that BBBY stock Investors Need to get a handle on where companys... Are going to go next surge in ZOM stock is up 786 % in 2021 for narrow... 15 minutes, all when does truforma launch at least 15 minutes, all others at least 15,.